Sulfasalazine Tablet
Product Images NDC 11534-200

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sulfasalazine (NDC 11534-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sunrise Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

This is a description of Sulfasalazine tablets in a bulk container. Each tablet contains 500 mg of sulfasalazine and there are 100 tablets in the container. The usual dosage information is provided in the accompanying prescribing information. It is important to note that this container is not intended for household use and should be dispensed in a well-closed container. The storage instructions recommend storing at 25°C (77°F) with excursions allowed to 15-30°C (59-86°F). This medication is manufactured for Sunrise Pharmaceutical, Inc. in Rahway, NJ.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

This text provides important information about a medication called Sulfasalazine, with each tablet containing 500 mg of the active ingredient. The usual dosage information is advised to be checked in the accompanying prescribing information. The tablets are USP approved and should be stored in a well-closed container at a temperature of 25°C (77°F) with excursions permitted to 15-30°C (59-86°F) as per USP Controlled Room Temperature guidelines. The medication is manufactured for Sunrise Pharmaceutical, Inc. located in Rahway, NJ.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

This text provides information about a medication with the NDC code 11534-200-04, containing 500mg of sulfasalazine per tablet. It indicates that the tablets should be dispensed as per the accompanying prescribing information and are not intended for household use. The storage conditions are specified as storing at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). The medication is manufactured for Sunrise Pharmaceutical, Inc. located in Rahway, NJ.*

FDA Label Image

Chemical Structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.